Federal award
HEMOGLOBIN OXYGEN THERAPEUTICS LLC
HT942525C0035
Contract
Obligated and Ceiling
- Obligated (net)
- $9,559,947.80
- Ceiling (potential value, not spending)
- $12,534,579.00
- Current value
- $12,534,579.00
- Gross positive obligations
- $9,559,947.80
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- HEMOGLOBIN OXYGEN THERAPEUTICS LLC · UJAMF5FC81N9
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- HEMOGLOBIN OXYGEN THERAPEUTICS LLC · UJAMF5FC81N9
- Awarding agency
- Department of War · sub-agency 97DH · office HT9427
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- HT942525C0035
- Award type code
- D
- Actions
- 7 · May 22, 2025 to Jun 16, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 16, 2026 | FY2026 | P00006 | B | $0.00 | — |
| Mar 16, 2026 | FY2026 | P00005 | M | $0.00 | — |
| Mar 4, 2026 | FY2026 | P00004 | M | $0.00 | — |
| Dec 15, 2025 | FY2026 | P00003 | C | $819,899.07 | — |
| Aug 25, 2025 | FY2025 | P00002 | C | $787,486.00 | — |
| Jul 10, 2025 | FY2025 | P00001 | B | $500,000.00 | — |
| May 22, 2025 | FY2025 | 0 | — | $7,452,562.73 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.